N-Ethylhexedrone was patented by the German pharmaceutical corporation Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[one]Which means that a negligible number of sample is needed for precise final results, conserving The remainder for evidence or long